The human mast cell line HMC-1 expresses c5a receptors and responds to C5a but not to C5(desArg)

Scandinavian Journal of Immunology

Volumn 44, Issue 1, 1996, Pages 30-36

  Werfel, T ^a,d   Oppermann, M ^b   Butterfield, J H ^c   Begemann, G ^a   Elsner, J ^a   Gotze O ^b   Zwirner, J ^b  

^a Medizinischen Hoch schule   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c MAYO CLINIC   (United States)

^d Hautklinik Linden   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A [DEARGININE]; MONOCLONAL ANTIBODY; RECEPTOR;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAST CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029885592     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-272.x     Document Type: Article

References (32)

1. Goldstein IM. Complement-biologically active products. In: Gallin JI, Goldstein IM. Snyderman R. eds. Inflammation: Basic Principles and Clinical Correlates. 2nd edn. New York: Raven Press, 1992;63-80.
2. Heuy R, Hugli TE. C5a receptor. Meth Enzymol 1987;150:615-27.
3. Werfel T, Oppermann M, Schulze M, Kreiger G, Weber M, Götze O. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 1992;79:152-60
4. Haviland DL, McCoy RL, Whitehead WT et al. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 1995;154:1861-9.
5. Werfel T, Witter W, Götze O. CD11b and CD11c antigens are rapidly increased on human natural killer cells upon activation. J Immunol 1991;147:2423-7.
6. Werfel T, Sonntag G, Weber M, Götze O. Rapid increases in the membrane expression of neutral endopepidase (CD45), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and FCγRIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991;147:3909-14.
7. Boulay F, Mery L, Tardif M, Brouchon L, Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 1991;30:2993-9.
8. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349:614-17.
9. Gerard C, Gerard NP. C5a anaphylatoxin and its seven transmembrane segment receptor. Annu Rev Immunol 1994;12:775-808.
10. Yancey KB, Hammer CH, Harvath L, Renfer L, Frank MM. Lawley TJ. Studies of human C5a as a mediator of imflammation in normal human skin. J Clin Invest 1985;75:486-95.
11. Swerlick RA, Yancey KB, Lawley TJ. A direct in vitro comparison of the inflammatory properties of human C5a and C5a des Arg in human skin. J Immunol 1988;140:2376-81.
12. Schulmann ES, Post TJ, Henson PM, Giclas PC. Differential effects of the complement peptides. C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 1988;81:918-23.
13. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994;102:803-6.
14. Gerard C, Chenoweth DE, Hugli TE. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5a des Arg-74 but not of C5a in biologic activity. J Immunol 1981;127:1978-82.
15. Bürgi B, Brunner T, Dahinden CA. The degradation product of the C5a anaphylatoxin C5adesArg retains basophil-activating properties. Eur J Immunol 1994;24:1583-9.
16. Oppermann M, Raedt U, Hebell T, Götze O. Probing the human receptor for C5a anaphylatoxin with site directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. J Immunol 1993;151:3785-94.
17. Montz H, Koch K-C, Zierz R, Götze O. The role of C5a in interleukin-6 production induced by lipolysaccharide or interleukin-1. Immunology 1991;74:373-9.
18. Hercend T, Meuer SC, Reinherz EL, Schlossmann SF, Ritz J. Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. J Immunol 1982;129:1299-305.
19. Oppermann M. CD88 (C5a receptor) cluster workshop report. In: Schlossman SF, ed. Leucocyte Typing V. Oxford: Oxford University Press, 1995;953 4.
20. Butterfield JH, Weiler D, Dewald G, Gleich GL. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-55.
21. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-71.
22. Elsner J, Kaever V, Emmendörffer A. Breidenbach T, Lohmann Matthes M-L. Roesler J. Heterogeneity in the mobilization of cytoplasmic calcium by human polymorphonuclear leukocytes in response to fMLP, C5a and 1L-8/NAP-1. J Leukoc Biol 1992;51:77-83.
23. Schwartz L, Huft T. Biology of mast cells and basophils. In Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy. Principles and Practice. 4th edn. St Louis: Mosby, 1993;135-68.
24. Nilsson G, Blom T, Kusche-Gullberg M et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994;39:489-98.
25. Grabbe J, Welker P, Moller A, Dippel E, Ashman LK, Czarnetzki BM. Comparative cytokine release from human monocytes, monocyte derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol 1994;103:504-8.
26. Selvan RS, Butterfield JH, Krangel MS. Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 1994;269:13893-8.
27. Götze O. The potential role of basophilic leukocytes and mast cells. Nephrol Dial Transplant 1994;9:57-9.
28. MacGlashan D Jr, Warner J. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and fMet-Leu-Phe. J Leuk Biol 1991;49:29-40.
29. Sklar LA, Oades ZG. Signal transduction and ligand-receptor dynamics in the human neutrophil. Ca2+ modulation and restoration. J Biol Chem 1985;260:11468-75.
30. van Epps DE, Simpson S, Chenoweth DE. C5a and formyl peptide receptor regulation on human monocytes. J Leukoc Biol 1992;51:393-9.
31. Bender JG, van Epps DE, Chenoweth DE. Independent regulation of human neutrophil chemotactic receptors after activation. J Immunol 1987;139:3028-33.
32. van Epps DE, Sipson S, Bender JG, Chenoweth DE. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J Immunol 1990;144:1062-8.